Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis.

Literature DB >> 21719607

Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis.

H Joachim Deeg, Frederick R Appelbaum.

Abstract

Entities: Disease Species

Mesh：

Year: 2011 PMID： 21719607 PMCID： PMC3143558 DOI： 10.1182/blood-2011-04-349142

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

× No keyword cloud information.

6 in total

Review 1. Who is fit for allogeneic transplantation?

Authors: H Joachim Deeg; Brenda M Sandmaier
Journal: Blood Date: 2010-08-11 Impact factor: 22.113

Review 2. How I treat myelofibrosis.

Authors: Ayalew Tefferi
Journal: Blood Date: 2011-01-03 Impact factor: 22.113

3. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

Authors: Marco Mielcarek; Paul J Martin; Wendy Leisenring; Mary E D Flowers; David G Maloney; Brenda M Sandmaier; Michael B Maris; Rainer Storb
Journal: Blood Date: 2003-03-27 Impact factor: 22.113

4. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.

Authors: Naseema Gangat; Domenica Caramazza; Rakhee Vaidya; Geeta George; Kebede Begna; Susan Schwager; Daniel Van Dyke; Curtis Hanson; Wenting Wu; Animesh Pardanani; Francisco Cervantes; Francesco Passamonti; Ayalew Tefferi
Journal: J Clin Oncol Date: 2010-12-13 Impact factor: 44.544

5. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.

Authors: James A Russell; A Robert Turner; Loree Larratt; Ahsan Chaudhry; Donald Morris; Christopher Brown; Diana Quinlan; Douglas Stewart
Journal: Biol Blood Marrow Transplant Date: 2007-03 Impact factor: 5.742

6. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.

Authors: Daniella M B Kerbauy; Theodore A Gooley; George E Sale; Mary E D Flowers; Kristine C Doney; George E Georges; Joanne E Greene; Michael Linenberger; Effie Petersdorf; Brenda M Sandmaier; Bart L Scott; Mohamed Sorror; Derek L Stirewalt; F Marc Stewart; Robert P Witherspoon; Rainer Storb; Frederick R Appelbaum; H Joachim Deeg
Journal: Biol Blood Marrow Transplant Date: 2007-03 Impact factor: 5.742

6 in total

3 in total